Aligos Therapeutics is a publicly traded biopharmaceutical company focused on discovering and developing targeted antiviral therapies for chronic hepatitis B (CHB), COVID-19, and nonalcoholic steatohepatitis (NASH). The company is headquartered at 1 Corporate Drive in South San Francisco, California, as listed on its website and the LLC filing. It trades on NASDAQ under the ticker ALGS.
Filed November 25, 2025 · South San Francisco, CA
Your competitors in South San Francisco are getting unlimited new business leads.
Aligos Therapeutics, Inc. is a biotechnology business (Corp) registered on November 25, 2025 with the California Division of Corporations. Its principal address is 1 Corporate Dr., 2nd Floor, South San Francisco, CA 94080.
Get owner name, phone, email, and website for newly registered businesses delivered to your inbox daily.
Start Your Free Trial ›Filing timeline will be available soon.
Aligos Therapeutics, Inc. was registered as Corp on November 25, 2025 in California.
Aligos Therapeutics, Inc.'s principal address on file is 1 Corporate Dr., 2nd Floor, South San Francisco, CA, 94080.
Aligos Therapeutics, Inc. is classified as a biotechnology business (antiviral therapies).
No EIN was found on file for Aligos Therapeutics, Inc. at the time of registration.
Based on the business category, these service providers typically target this type of business.